The partnership between is expected to improve access and help overcome gaps in care for consumers.
CVS did it with Caremark, Rite Aid did it with Envision, and now it’s Walgreens’ turn. The partnership between Walgreens Boots Alliance and OptumRx (the pharmacy benefit management wing of UnitedHealth) is expected to improve access to drugs for consumers.
According to an announcement by the UnitedHealth group, the integration will allow:
“We are excited to be working with Walgreens to create a new pharmacy solution that provides convenience and cost savings, and goes beyond filling prescriptions to deliver a more valuable pharmacy and health management experience for consumers,” said Larry Renfro, chief executive officer of Optum, in a statement.
Analysts predict that this partnership will help boost drug sales for Walgreens. However, some members with drug coverage from Optum might end up having to fill-in their prescriptions only at a Walgreens pharmacy, depending on the contract signed by their employers or drug benefits plan.
Both Walgreens and OptumRx expect that this partnership would have a significant impact on patient adherence and closing the gaps in care. “The deal will give pharmacists more access to information that will help them counsel patients who are on multiple drugs, aren’t getting refills, or taking pills that shouldn’t be taken together,” said Mark Thierer, chief executive officer of OptumRx.
The integrated pharmacy care will be available to commercial clients at the beginning of 2017.
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from the Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen